Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Apr 22, 2009

Premium

Frank Witney has left his positions at Affymetrix as executive VP and chief commercial officer to serve as president and CEO of the chemical chromatography systems maker Dionex. He replaces Lukas Braunschweiler, who has been president and CEO of Dionex since 2002. Braunschweiler left the post to serve as president and CEO of Ruag Holding.

Witney was president of drug discovery tools at PerkinElmer and he was president and CEO of Panomics before it was purchased last year by Affymetrix.


Mitrionics, a developer of parallel processing software and accelerated hybrid computing servers, has appointed Dietrich Stephan as its first scientific advisory board member.

Stephan is the co-founder and chief science officer for the consumer genomics firms Navigenics, chairman of the National Institutes of Health Neuroscience Microarray Consortium, and founding chairman of the neurogenomics division of the Translational Genomics Research Institute.


Karine Hovanes has joined Combimatrix Molecular Diagnostics as its new laboratory director. Prior to joining Combimatrix, Hoyanes was assistant lab director of US Labs, now a part of Laboratory Corporation of America.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.